Mechanistically, ICIs synergize with TILs by alleviating PD-1/PD-L1-mediated T cell suppression and amplifying tumor antigen-specific cytotoxicity, thereby remodeling the immunosuppressive microenvironment (20, 88). This evidence concerns the gene CD274 and neoplasm.